Cargando…

Antagonization of the Nogo-Receptor 1 Enhances Dopaminergic Fiber Outgrowth of Transplants in a Rat Model of Parkinson’s Disease

Intrastriatal transplantation of fetal human ventral mesencephalic dopaminergic neurons is an experimental therapy for patients suffering from Parkinson’s disease. The success of this approach depends on several host brain parameters including neurotrophic factors and growth inhibitors that guide su...

Descripción completa

Detalles Bibliográficos
Autores principales:	Seiler, Stefanie, Di Santo, Stefano, Andereggen, Lukas, Widmer, Hans R.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2017
Materias:	Neuroscience
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5445167/ https://www.ncbi.nlm.nih.gov/pubmed/28603490 http://dx.doi.org/10.3389/fncel.2017.00151

Ejemplares similares

Co-Expression of Nogo-A in Dopaminergic Neurons of the Human Substantia Nigra Pars Compacta Is Reduced in Parkinson’s Disease
por: Eyer, Gian-Carlo, et al.
Publicado: (2021)

Nogo-A Neutralization Improves Graft Function in a Rat Model of Parkinson’s Disease
por: Seiler, Stefanie, et al.
Publicado: (2016)

Nogo-A and its functions beyond axonal inhibition: the controversial role of Nogo-A in Parkinson's disease
por: Seiler, Stefanie, et al.
Publicado: (2015)

Simultaneous Transplantation of Fetal Ventral Mesencephalic Tissue and Encapsulated Genetically Modified Cells Releasing GDNF in a Hemi-Parkinsonian Rat Model of Parkinson’s Disease
por: Perez-Bouza, Alberto, et al.
Publicado: (2017)

Decreased soluble Nogo-B in serum as a promising biomarker for Parkinson's disease
por: Liang, Hongming, et al.
Publicado: (2022)

Neurotrophic factor-based strategies to enhance survival and differentiation of neural progenitor cells toward the dopaminergic phenotype
por: Di Santo, Stefano, et al.
Publicado: (2018)

A Combination of NT-4/5 and GDNF Is Favorable for Cultured Human Nigral Neural Progenitor Cells
por: Di Santo, Stefano, et al.
Publicado: (2018)

Extracellular Pgk1 enhances neurite outgrowth of motoneurons through Nogo66/NgR-independent targeting of NogoA
por: Lin, Cheng Yung, et al.
Publicado: (2019)

Application of Antibodies to Neuronally Expressed Nogo-A Increases Neuronal Survival and Neurite Outgrowth
por: Nagaraj, Vini, et al.
Publicado: (2020)

Reduced Expression of Nogo-A Leads to Motivational Deficits in Rats
por: Enkel, Thomas, et al.
Publicado: (2014)

Endothelial Progenitor Cells Conditioned Medium Supports Number of GABAergic Neurons and Exerts Neuroprotection in Cultured Striatal Neuronal Progenitor Cells
por: Santo, Stefano Di, et al.
Publicado: (2019)

Endothelial Progenitor Cell-Derived Factors Exert Neuroprotection in Cultured Cortical Neuronal Progenitor Cells
por: Santo, Stefano Di, et al.
Publicado: (2020)

Vulnerability of Mesostriatal Dopaminergic Neurons in Parkinson's Disease
por: González-Hernández, Tomás, et al.
Publicado: (2010)

Dopaminergic modulation of emotional conflict in Parkinson's disease
por: Fleury, Vanessa, et al.
Publicado: (2014)

Neuromelanin Imaging and Dopaminergic Loss in Parkinson's Disease
por: Isaias, Ioannis U., et al.
Publicado: (2016)

Paracrine factors for neurodegenerative disorders: special emphasis on Parkinson's disease
por: Di Santo, Stefano, et al.
Publicado: (2016)

Schwann Cell Expressed Nogo-B Modulates Axonal Branching of Adult Sensory Neurons Through the Nogo-B Receptor NgBR
por: Eckharter, Christoph, et al.
Publicado: (2015)

Influence of Depressive Symptoms on Dopaminergic Treatment of Parkinson’s Disease
por: Hanganu, Alexandru, et al.
Publicado: (2014)

Roles of FGF20 in dopaminergic neurons and Parkinson's disease
por: Itoh, Nobuyuki, et al.
Publicado: (2013)

Asymmetric Dopaminergic Degeneration and Attentional Resources in Parkinson’s Disease
por: Ortelli, Paola, et al.
Publicado: (2018)

Peripheral Neuron Survival and Outgrowth on Graphene
por: Convertino, Domenica, et al.
Publicado: (2018)

Neuropsychiatric Disorders in Parkinson’s Disease: What Do We Know About the Role of Dopaminergic and Non-dopaminergic Systems?
por: Dujardin, Kathy, et al.
Publicado: (2020)

Anti-inflammatory cytokine-eluting collagen hydrogel reduces the host immune response to dopaminergic cell transplants in a rat model of Parkinson’s disease
por: Cabré, Sílvia, et al.
Publicado: (2021)

The Secretome of Endothelial Progenitor Cells Promotes Brain Endothelial Cell Activity through PI3-Kinase and MAP-Kinase
por: Di Santo, Stefano, et al.
Publicado: (2014)

Effect of Dopaminergic Medication on Postural Sway in Advanced Parkinson’s Disease
por: Revilla, Fredy J., et al.
Publicado: (2013)

Molecular determinants of selective dopaminergic vulnerability in Parkinson’s disease: an update
por: Brichta, Lars, et al.
Publicado: (2014)

Degeneration of Dopaminergic Neurons Due to Metabolic Alterations and Parkinson’s Disease
por: Song, Juhyun, et al.
Publicado: (2016)

Improved neurite outgrowth on central nervous system myelin substrate by siRNA-mediated knockdown of Nogo receptor
por: Ding, Sheng-Hao, et al.
Publicado: (2016)

Anti-Nogo-A Immunotherapy Does Not Alter Hippocampal Neurogenesis after Stroke in Adult Rats
por: Shepherd, Daniel J., et al.
Publicado: (2016)

The Effect of Dopaminergic Medication on Beat-Based Auditory Timing in Parkinson’s Disease
por: Cameron, Daniel J., et al.
Publicado: (2016)

Dopaminergic and Opioid Pathways Associated with Impulse Control Disorders in Parkinson’s Disease
por: Erga, Aleksander H., et al.
Publicado: (2018)

Distinct Role of Striatal Functional Connectivity and Dopaminergic Loss in Parkinson’s Symptoms
por: Dukart, Juergen, et al.
Publicado: (2017)

Dopaminergic and Metabolic Correlations With Cognitive Domains in Non-demented Parkinson’s Disease
por: Han, Linlin, et al.
Publicado: (2021)

Differential dopaminergic modulation of spontaneous cortico–subthalamic activity in Parkinson’s disease
por: Sharma, Abhinav, et al.
Publicado: (2021)

Selective dopaminergic vulnerability in Parkinson’s disease: new insights into the role of DAT
por: Harraz, Maged M.
Publicado: (2023)

Enhanced Go and NoGo Learning in Individuals With Obesity
por: Kube, Jana, et al.
Publicado: (2020)

Substantia Nigra Hyperechogenicity Reflects the Progression of Dopaminergic Neurodegeneration in 6-OHDA Rat Model of Parkinson’s Disease
por: Zhang, Siyan, et al.
Publicado: (2020)

Female Rats Are Resistant to Cognitive, Motor and Dopaminergic Deficits in the Reserpine-Induced Progressive Model of Parkinson’s Disease
por: Lima, Alvaro C., et al.
Publicado: (2021)

The Role of Sartans in the Treatment of Stroke and Subarachnoid Hemorrhage: A Narrative Review of Preclinical and Clinical Studies
por: Wanderer, Stefan, et al.
Publicado: (2020)

Targeted inhibition of the Shroom3–Rho kinase protein–protein interaction circumvents Nogo66 to promote axon outgrowth
por: Dickson, Heather M, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_kh1tifufcg8r5jp8p7pn1m02uq